Literature DB >> 27221540

Genomic Landscape of Colorectal Mucosa and Adenomas.

Ester Borras1, F Anthony San Lucas2, Kyle Chang3, Ruoji Zhou3, Gita Masand1, Jerry Fowler4, Maureen E Mork5, Y Nancy You6, Melissa W Taggart7, Florencia McAllister8, David A Jones9, Gareth E Davies10, Winfried Edelmann11, Erik A Ehli10, Patrick M Lynch12, Ernest T Hawk1, Gabriel Capella13, Paul Scheet14, Eduardo Vilar15.   

Abstract

The molecular basis of the adenoma-to-carcinoma transition has been deduced using comparative analysis of genetic alterations observed through the sequential steps of intestinal carcinogenesis. However, comprehensive genomic analyses of adenomas and at-risk mucosa are still lacking. Therefore, our aim was to characterize the genomic landscape of colonic at-risk mucosa and adenomas. We analyzed the mutation profile and copy number changes of 25 adenomas and adjacent mucosa from 12 familial adenomatous polyposis patients using whole-exome sequencing and validated allelic imbalances (AI) in 37 adenomas using SNP arrays. We assessed for evidence of clonality and performed estimations on the proportions of driver and passenger mutations using a systems biology approach. Adenomas had lower mutational rates than did colorectal cancers and showed recurrent alterations in known cancer driver genes (APC, KRAS, FBXW7, TCF7L2) and AIs in chromosomes 5, 7, and 13. Moreover, 80% of adenomas had somatic alterations in WNT pathway genes. Adenomas displayed evidence of multiclonality similar to stage I carcinomas. Strong correlations between mutational rate and patient age were observed in at-risk mucosa and adenomas. Our data indicate that at least 23% of somatic mutations are present in at-risk mucosa prior to adenoma initiation. The genomic profiles of at-risk mucosa and adenomas illustrate the evolution from normal tissue to carcinoma via greater resolution of molecular changes at the inflection point of premalignant lesions. Furthermore, substantial genomic variation exists in at-risk mucosa before adenoma formation, and deregulation of the WNT pathway is required to foster carcinogenesis. Cancer Prev Res; 9(6); 417-27. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27221540      PMCID: PMC4941624          DOI: 10.1158/1940-6207.CAPR-16-0081

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  32 in total

1.  Possible involvement of Wnt11 in colorectal cancer progression.

Authors:  Mitsuaki Nishioka; Koji Ueno; Shoichi Hazama; Toshiyuki Okada; Kouhei Sakai; Yutaka Suehiro; Naoko Okayama; Hiroshi Hirata; Masaaki Oka; Kohzoh Imai; Rajvir Dahiya; Yuji Hinoda
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps.

Authors:  Daniela Hirsch; Jordi Camps; Sudhir Varma; Ralf Kemmerling; Mark Stapleton; Thomas Ried; Timo Gaiser
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

3.  Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.

Authors:  Tatiana Cajuso; Ulrika A Hänninen; Johanna Kondelin; Alexandra E Gylfe; Tomas Tanskanen; Riku Katainen; Esa Pitkänen; Heikki Ristolainen; Eevi Kaasinen; Minna Taipale; Jussi Taipale; Jan Böhm; Laura Renkonen-Sinisalo; Jukka-Pekka Mecklin; Heikki Järvinen; Sari Tuupanen; Outi Kilpivaara; Pia Vahteristo
Journal:  Int J Cancer       Date:  2014-01-13       Impact factor: 7.396

4.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Authors:  A B Sparks; P J Morin; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

Review 5.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.

Authors:  Eva Maria Kohler; Adrian Derungs; Gabriele Daum; Jürgen Behrens; Jean Schneikert
Journal:  Hum Mol Genet       Date:  2008-04-02       Impact factor: 6.150

7.  Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.

Authors:  Cristian Tomasetti; Bert Vogelstein; Giovanni Parmigiani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  Haplotype-based profiling of subtle allelic imbalance with SNP arrays.

Authors:  Selina Vattathil; Paul Scheet
Journal:  Genome Res       Date:  2012-10-01       Impact factor: 9.043

10.  A Big Bang model of human colorectal tumor growth.

Authors:  Andrea Sottoriva; Haeyoun Kang; Zhicheng Ma; Trevor A Graham; Matthew P Salomon; Junsong Zhao; Paul Marjoram; Kimberly Siegmund; Michael F Press; Darryl Shibata; Christina Curtis
Journal:  Nat Genet       Date:  2015-02-09       Impact factor: 38.330

View more
  35 in total

1.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

Review 2.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 3.  Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.

Authors:  Lu Zhang; Jerry W Shay
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

Review 4.  New insights into the earliest stages of colorectal tumorigenesis.

Authors:  Chelsie K Sievers; William M Grady; Richard B Halberg; Perry J Pickhardt
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 3.869

Review 5.  Genomic approaches to accelerate cancer interception.

Authors:  Jennifer Beane; Joshua D Campbell; Julian Lel; Jessica Vick; Avrum Spira
Journal:  Lancet Oncol       Date:  2017-07-26       Impact factor: 41.316

6.  Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.

Authors:  Y Nancy You; Ester Borras; Kyle Chang; Brandee A Price; Maureen Mork; George J Chang; Miguel A Rodriguez-Bigas; Brian K Bednarski; Funda Meric-Bernstam; Eduardo Vilar
Journal:  Dis Colon Rectum       Date:  2019-04       Impact factor: 4.585

Review 7.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

8.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.

Authors:  Miguel Crespo; Eduardo Vilar; Su-Yi Tsai; Kyle Chang; Sadaf Amin; Tara Srinivasan; Tuo Zhang; Nina H Pipalia; Huanhuan Joyce Chen; Mavee Witherspoon; Miriam Gordillo; Jenny Zhaoying Xiang; Frederick R Maxfield; Steven Lipkin; Todd Evans; Shuibing Chen
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

9.  Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.

Authors:  K Chang; J A Willis; J Reumers; M W Taggart; F A San Lucas; S Thirumurthi; P Kanth; D A Delker; C H Hagedorn; P M Lynch; L M Ellis; E T Hawk; P A Scheet; S Kopetz; J Arts; J Guinney; R Dienstmann; E Vilar
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

10.  Clinicopathological and molecular correlations in traditional serrated adenoma.

Authors:  Shigeki Sekine; Satoshi Yamashita; Masayoshi Yamada; Taiki Hashimoto; Reiko Ogawa; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Toshikazu Ushijima; Yutaka Saito
Journal:  J Gastroenterol       Date:  2020-02-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.